IQV

— Fundamental Stock Analysis and Report Card

Healthcare : Medical - Diagnostics & Research

Located in Durham, NC, US. IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
26.11%
EBITDA Margin TTM
21.16%
Net Margin TTM
8.33%
Earnings Per Share TTM
8.22
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

IQVIA Holdings Inc.
Select Period:
Q1 2026
Total ($)
Q1 2026
Margin (%)
Revenue
4.2b
+322.0m
+8.4%
Gross Income
1.4b
+57.0m
+4.4%
33%
-1.3pp
-3.7%
EBITDA
808.0m
+55.0m
+7.3%
19%
-0.2pp
-1.0%
Operating Income
514.0m
+18.0m
+3.6%
12%
-0.6pp
-4.4%
Net Income
274.0m
+25.0m
+10.0%
7%
+0.1pp
+1.5%
Earnings Per Share
1.63
+0.2
+14.8%
Operating Cash Flow
618.0m
+50.0m
+8.8%
15%
+0.1pp
+0.4%
Free Cash Flow
491.0m
+65.0m
+15.3%
12%
+0.7pp
+6.3%
Research & Development
n/a
n/a
n/a
n/a
n/a
n/a